News & Updates

Serum levels of adalimumab at week 2 is associated with short-term clinical remission in patients with inflammatory bowel disease (IBD), a study has shown.

Patients with COVID-19 show very low levels of 25-hydroxyvitamin D and zinc, regardless of age, sex, and comorbidities, reports a study. Vitamin D and zinc deficiency appears to be relevant factors in identifying individuals who are susceptible to SARS-CoV-2 infection.

A recent study has found that less than half of patients with alcohol-induced acute pancreatitis (AAP) receive alcohol counseling.

Rocatinlimab improved disease severity in patients with moderate-to-severe head and neck atopic dermatitis (H&N AD), a post hoc analysis of a phase IIb trial has shown.

Children suffering from bronchiectasis may benefit from a play-based therapeutic exercise regimen, which results in better fitness and fundamental movement skill (FMS), according to a recent pilot trial.

PCSK9 inhibition with evolocumab produces clinically meaningful and sustained reductions in certain lipid parameters in a predominantly Arabic population of individuals with familial hypercholesterolaemia (FH) and other non-FH indications, according to a study.

Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.

Patients with chronic lymphocytic leukaemia (CLL) may benefit from an exercise regimen consisting of high-intensity interval training (HIIT) and resistance training (RT), which could lead to better functional and general wellbeing, as well as a lower burden of lymphoma-specific symptoms, reports a recent study.

Delayed intake of a progestogen-only pill (POP) or missing one pill does not necessarily reduce its theoretical contraceptive protection, with little effect on cervical mucus and ovulation, as shown in a study.

An intensive weight-loss intervention has failed to substantially improve the treatment outcomes among obese patients with nonalcoholic fatty liver disease (NAFLD), reports a recent study.